Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Medical genetics Stories

2013-07-22 12:25:05

Agreement Preserves Popular, Free Genetic Laboratory Service to Medical Community ELMWOOD PARK, N.J., July 22, 2013 /PRNewswire/ -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (www.bioreference.com) announced today that it signed a licensing agreement with the University of Washington to transition GeneTests.org, GeneClinics.org and all other related properties to become a business unit of Bio-Reference. Since 1992, GeneTests.org has been a key resource for physicians,...

2013-07-22 08:29:12

SHENZHEN, China, July 22, 2013 /PRNewswire/ -- The largest genomic institute of the world, BGI Shenzhen, China (hereinafter BGI), together with Reproductive & Genetic Hospital CITIC-XIANGYA (hereinafter CITIC-XIANGYA) announced today that they have successfully applied Next Generation Sequencing (NGS) to detect in vitro fertilized (IVF) embryos with genetic abnormalities. The successful application of preimplantation sequencing (the most advanced form of preimplantation genetic...

2013-07-19 12:24:48

BETHESDA, Md., July 19, 2013 /PRNewswire-USNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) is concerned with the enactment of laws in some states that prevent or restrict access to termination of pregnancy after prenatal diagnosis of genetic disorders or congenital anomalies. The practice of medical genetics is predicated on the principle of providing patients with accurate information on the genetic disorder or congenital anomaly that affects them, a member...

2013-07-08 12:28:17

Investment will fund growth strategies; specialty services ST. PETERSBURG, Fla., July 8, 2013 /PRNewswire-USNewswire/ -- InformedDNA, the largest independent U.S. provider of genetic counseling and genetic benefits management services, announced today that MPM Capital, a life science-dedicated venture investment firm has acquired a minority stake in the company. The investment fr­om MPM's SunStates Fund, LP will be used to expand InformedDNA's current genetic benefits utilization...

First IVF Baby Born Using NGS
2013-07-08 10:43:35

Brett Smith for redOrbit.com - Your Universe Online Next generation sequencing (NGS) techniques have allowed scientists to sequence DNA at faster rates than ever before, and in the process they have begun to revolutionize fields as disparate as anthropology and botany. The technology is also now being used to screen embryos for in vitro fertilization (IVF), and the first child to ever pass though that screening process was recently born in the United States. Developed in the UK at...

2013-07-03 23:17:32

In light of recent research developing a test to screen for Inborn Errors of Metabolism disorders, Kwiksure examines if genetic screening tests could be covered by insurers. Hong Kong (PRWEB) July 03, 2013 According to the Chinese University of Hong Kong (CUHK), one out of 4000 babies born in Hong Kong will be diagnosed with Inborn Errors of Metabolism (IEM). These metabolic disorders can lead to several health defects but recent research has developed a genetic screening test to detect...

2013-07-03 15:11:13

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer. That is among the findings of a new study from Georgetown Lombardi Comprehensive Cancer Center, which also suggests mothers who don't discuss their test results are unsatisfied with that decision. "We know from women we've counseled at Georgetown that one of their main considerations...

2013-06-26 20:21:03

Largest MDA golf tournament in the U.S. has a combined contribution of $3.7 million GAINESVILLE, Ga., June 26, 2013 /PRNewswire-iReach/ -- Mansfield Oil held the 27th Annual Mansfield Oil Golf Classic on June 11th and raised over $500,000 for the Muscular Dystrophy Association (MDA), a record for this event. The Annual Mansfield Oil Golf Classic is the largest MDA golf tournament in the U.S., and since its inception 27 years ago, the event has raised a collective $3.7 million for the...

2013-06-19 23:17:29

Nineteen gene panel provides the most comprehensive hereditary cancer analysis clinically available. Salt Lake City, UT (PRWEB) June 19, 2013 Ethigen announced today the US launch of their expanded BRCA1 and BRCA2 testing service, providing next-generation sequencing (NGS) and rearrangement analysis of both genes. Analysis is available individually, or as part of an expanded hereditary cancer panel, including full coverage of up to seventeen additional genes with known links to cancer risk:...

2013-06-19 12:27:39

Media are Invited to Register Now For a Live, CAP-Exclusive Event WASHINGTON, June 19, 2013 /PRNewswire-USNewswire/ -- Genomic medicine has the potential to be a cornerstone of medical testing, treatment, and clinical integration. Without doubt, the Supreme Court's unanimous decision invalidating Myriad's patents on BRCA1 and BRCA2 is already changing the testing landscape for those genes. What other changes can we expect? How will the decision impact medical testing? What did it...